News Industry News Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events August 20, 2015
News Industry News Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions June 05, 2015
Presentation TCT 2013 Importance of Optimal Reperfusion in Diabetic Patients Treated with Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Presenter: M.A. Velders, H. Boden, B.L. van der Hoeven, AACM Heestermans, VAWM Umans, SH Hofma, JW Jukema, M.J. Schalij, A. J. van Boven January 31, 2013
Presentation TCT 2013 Clinical Impact of Five-month Follow-up Glycosylated Hemoglobin on Cardiovascular Outcomes in Diabetic Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primar... Presenter: Jinhee Ahn, Kwang Soo Cha, Jeong Cheon Choi, Jung Hyun Choi, Jong Hyun Choi, Taek Jong Hong, Hye Yoon Jang, Han Cheol Lee, Jun-Hyok Oh January 31, 2013
News Daily News CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term Yael L. Maxwell January 09, 2013
News Conference News AHA 2012 EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES Jason Kahn November 04, 2012
News Conference News RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority August 31, 2011
News Daily News HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics Jason Kahn July 18, 2011
News Daily News Studies Support DES Use in Diabetics, But Results Vary by Device Caitlin E. Cox March 08, 2011